J&J Recalling Thousands of Tylenol Bottles
Johnson & Johnson (NYSE:JNJ) is recalling yet another batch of Tylenol because of complaints of a moldy stench.
The company’s McNeil Consumer Healthcare Division is taking back roughly 34,000 bottles of Tylenol 8-Hour Extended Release caplets manufactured at its plant in Fort Washington, Pennsylvania prior to April 2010 and distributed in the U.S.
J&J advised consumers to stop taking the drug and contact the company for a refund.
The consumer products company said the musty odor is thought to be caused by the presence of trace amounts of chemicals called 2,4,6-tribromoanisole and 2,4,6-trichloroanisole. J&J said the recall is being taken as a precaution and the risk of adverse medical events is remote.
The company is also adding 10 lots of other products to a wholesale level recall initiated on January and comprising nearly 717,696 bottles of various Tylenol, Benadryl and Sudafed products.
J&J said the recall doesn’t require action by consumers or doctors and wasn’t undertaken on the basis of adverse events. It was taken as a precautionary measure after a review a past manufacturing records found cases where equipment cleaning procedures were insufficient, or inadequately documented.
The New Brunswick, N.J.-based company has recalled more than 300 million bottles and packages of adult and children's consumer medicines in the past 15 months.